SCHEMBL22445604

SCHEMBL22445604

N[C@H](C=O)c1ccccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
HTT P42858 1/20 0.35
CYP2C19 P33261 2/20 0.33
CYP2C9 P11712 1/20 0.33
CA5A P35218 1/20 0.33
CA9 Q16790 1/20 0.33
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD11B1 P28845 2/20 0.31
GAA P10253 1/20 0.30
TAAR1 Q96RJ0 1/20 0.30
OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5813998 0.78 IDO1 (0.40) IDO1TDO2CA1CA2CA4
SCHEMBL2559434 0.77 IDO1 (0.38) IDO1TDO2CA1CA2CA4
SCHEMBL21495057 0.76 IDO1 (0.37) IDO1TDO2CA1CA2CA4
SCHEMBL166469 0.76 IDO1 (0.37) IDO1TDO2CA1CA2CA4
SCHEMBL9818286 0.74 HTT (0.42) IDO1TDO2CA1CA2CA4
SCHEMBL2513507 0.74 GABRA1 (0.46) CA2CA4CA5AALDH1A1CYP3A4
SCHEMBL7195097 0.74 IDO1 (0.40) IDO1TDO2CYP2C9ALDH1A1CYP3A4
SCHEMBL24017066 0.74 IDO1 (0.47) IDO1TDO2CA1CA2CA4
SCHEMBL3256312 0.74 IDO1 (0.47) IDO1TDO2CA1CA2CA4
SCHEMBL3675827 0.74 IDO1 (0.47) IDO1TDO2CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3941905-A1 SUMO INHIBITOR COMPOUNDS AND USES THEREOF Suvalent Therapeutics, Inc. (US) 2022-01-26 EP disclosed
WO-2020191151-A1 SUMO INHIBITOR COMPOUNDS AND USES THEREOF ONCOVALENT THERAPEUTICS INC. (US) 2020-09-24 WO disclosed